SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics
Abstract Background The FDA approval of T cell receptor-engineered T cells (TCR-T) for synovial sarcoma demonstrates the potential for adoptive T cell therapies (ACTs) in solid tumors. However, the paucity of tumor-associated targets without expression in normal tissues remains a major bottleneck, e...
Saved in:
| Main Authors: | Stefano Testa, Aastha Pal, Ajay Subramanian, Sushama Varma, Jack Pengfei Tang, Danielle Graham, Sara Arfan, Minggui Pan, Nam Q. Bui, Kristen N. Ganjoo, Sarah Dry, Paul Huang, Matt van de Rijn, Wei Jiang, Anusha Kalbasi, Everett J. Moding |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Genome Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13073-025-01514-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report of non-gene editing CD7 CAR T cell therapy in CD7+ Sézary syndrome: preclinical validation and first-in-human use
by: Haichan Xu, et al.
Published: (2025-08-01) -
Application and prospects of genetic engineering in CAR-NK cell therapy
by: Caidong Hu, et al.
Published: (2025-05-01) -
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
by: Yong Liu, et al.
Published: (2025-07-01) -
TIGIT blockade in the context of BCMA-CART cell therapy does not augment efficacy in a multiple myeloma mouse model
by: Aina Oliver-Caldes, et al.
Published: (2025-12-01) -
Research on strategies to inhibit CAR-T cell exhaustion
by: FU Qiongyu, HAO Xinbao, TAO Shi
Published: (2025-04-01)